Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/jjco/hyaa077 http://scihub22266oqcxt.onion/10.1093/jjco/hyaa077 32415305!7239118!32415305     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Jpn+J+Clin+Oncol 2020 ; 50 (6): 712-717 Nephropedia Template TP {{tp|p=32415305|t=2020. When cancer encounters COVID-19 in China: what have we suffered, experienced and learned |pdf=|usr=}}{{32415305}} gab.com Text When cancer encounters COVID-19 in China: what have we suffered, experienced and learned JO: Jpn J Clin Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32415305 #FOAvip The outbreak of the coronavirus disease (COVID-19) occurred in Wuhan, China, in December 2019. As of 21 March 2020, this epidemic has spread to 179 countries with more than 200 000 confirmed cases and 8578 deaths. The outbreak has put enormous pressure on the medical establishment and even led to exhaustion of medical resources in the most affected areas. Other medical work has been significantly affected in the context of COVID-19 epidemic. In order to reduce or avoid cross-infection with COVID-19, many hospitals have taken measures to limit the number of outpatient visits and inpatients. For example, emergency surgery can only be guaranteed, and most other surgeries can be postponed. Patients with cancer are one of the groups most affected by the epidemic because of their systematic immunosuppressive state and requirement of frequent admission to hospital. Consequently, specific adjustments for their treatment need to be made to cope with this situation. Therefore, it is of significance to summarize the relevant experience of China in the prevention and control of COVID-19 infection and treatment of patients with cancer during the epidemic. Twit Text FOAVip When cancer encounters COVID-19 in China: what have we suffered, experienced and learned ????Jpn J Clin Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32415305 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32415305 #FOAvip English Wikipedia <ref>{{Cite pmid|32415305}}</ref> When cancer encounters COVID-19 in China: what have we suffered, experienced and learned #MMPMID32415305 Chen H; Wu X; Wang W; Wang Q Jpn J Clin Oncol 2020[Jun]; 50 (6): 712-717 PMID32415305show ga The outbreak of the coronavirus disease (COVID-19) occurred in Wuhan, China, in December 2019. As of 21 March 2020, this epidemic has spread to 179 countries with more than 200 000 confirmed cases and 8578 deaths. The outbreak has put enormous pressure on the medical establishment and even led to exhaustion of medical resources in the most affected areas. Other medical work has been significantly affected in the context of COVID-19 epidemic. In order to reduce or avoid cross-infection with COVID-19, many hospitals have taken measures to limit the number of outpatient visits and inpatients. For example, emergency surgery can only be guaranteed, and most other surgeries can be postponed. Patients with cancer are one of the groups most affected by the epidemic because of their systematic immunosuppressive state and requirement of frequent admission to hospital. Consequently, specific adjustments for their treatment need to be made to cope with this situation. Therefore, it is of significance to summarize the relevant experience of China in the prevention and control of COVID-19 infection and treatment of patients with cancer during the epidemic. |Betacoronavirus[MESH] |COVID-19[MESH] |China/epidemiology[MESH] |Coronavirus Infections/*epidemiology/prevention & control[MESH] |Cross Infection/prevention & control[MESH] |Hospitals/standards[MESH] |Humans[MESH] |Infection Control/standards[MESH] |Neoplasms/diagnosis/*therapy[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*epidemiology/prevention & control[MESH] |Practice Guidelines as Topic[MESH]When cancer encounters COVID-19 in China: what have we suffered, exper(epmc).pdf DeepDyve Pubget Overpricing